154 related articles for article (PubMed ID: 24130605)
1. Effects of zinc supplementation in patients with major depression: a randomized clinical trial.
Ranjbar E; Kasaei MS; Mohammad-Shirazi M; Nasrollahzadeh J; Rashidkhani B; Shams J; Mostafavi SA; Mohammadi MR
Iran J Psychiatry; 2013 Jun; 8(2):73-9. PubMed ID: 24130605
[TBL] [Abstract][Full Text] [Related]
2. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study.
Nowak G; Siwek M; Dudek D; Zieba A; Pilc A
Pol J Pharmacol; 2003; 55(6):1143-7. PubMed ID: 14730113
[TBL] [Abstract][Full Text] [Related]
3. Effects of zinc, vitamin D, and their co-supplementation on mood, serum cortisol, and brain-derived neurotrophic factor in patients with obesity and mild to moderate depressive symptoms: A phase II, 12-wk, 2 × 2 factorial design, double-blind, randomized, placebo-controlled trial.
Yosaee S; Soltani S; Esteghamati A; Motevalian SA; Tehrani-Doost M; Clark CCT; Jazayeri S
Nutrition; 2020 Mar; 71():110601. PubMed ID: 31837640
[TBL] [Abstract][Full Text] [Related]
4. Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: a double-blind, randomized, placebo-controlled trial.
Solati Z; Jazayeri S; Tehrani-Doost M; Mahmoodianfard S; Gohari MR
Nutr Neurosci; 2015 May; 18(4):162-8. PubMed ID: 24621065
[TBL] [Abstract][Full Text] [Related]
5. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
6. Investigating the effect of magnesium supplement in patients with major depressive disorder under selective serotonin reuptake inhibitor treatment.
Nazarinasab M; Behrouzian F; Abdi L; Sadegh Moghaddam AA; Sadeghi S
J Family Med Prim Care; 2022 Dec; 11(12):7800-7805. PubMed ID: 36994048
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 supplementation effects on body weight and depression among dieter women with co-morbidity of depression and obesity compared with the placebo: A randomized clinical trial.
Keshavarz SA; Mostafavi SA; Akhondzadeh S; Mohammadi MR; Hosseini S; Eshraghian MR; Chamari M
Clin Nutr ESPEN; 2018 Jun; 25():37-43. PubMed ID: 29779816
[TBL] [Abstract][Full Text] [Related]
8. Zinc sulphate: A reasonable choice for depression management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial.
Salari S; Khomand P; Arasteh M; Yousefzamani B; Hassanzadeh K
Pharmacol Rep; 2015 Jun; 67(3):606-9. PubMed ID: 25933976
[TBL] [Abstract][Full Text] [Related]
9. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
10. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
Honig A; Kuyper AM; Schene AH; van Melle JP; de Jonge P; Tulner DM; Schins A; Crijns HJ; Kuijpers PM; Vossen H; Lousberg R; Ormel J;
Psychosom Med; 2007; 69(7):606-13. PubMed ID: 17846258
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
[TBL] [Abstract][Full Text] [Related]
12. Randomized, Double-Blind, Placebo-Controlled Trial of the mGlu2/3 Negative Allosteric Modulator Decoglurant in Partially Refractory Major Depressive Disorder.
Umbricht D; Niggli M; Sanwald-Ducray P; Deptula D; Moore R; Grünbauer W; Boak L; Fontoura P
J Clin Psychiatry; 2020 Jul; 81(4):. PubMed ID: 32663909
[TBL] [Abstract][Full Text] [Related]
13. Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.
Levitan RD; Shen JH; Jindal R; Driver HS; Kennedy SH; Shapiro CM
J Psychiatry Neurosci; 2000 Sep; 25(4):337-46. PubMed ID: 11022398
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
Quiroz JA; Tamburri P; Deptula D; Banken L; Beyer U; Rabbia M; Parkar N; Fontoura P; Santarelli L
JAMA Psychiatry; 2016 Jul; 73(7):675-84. PubMed ID: 27304433
[TBL] [Abstract][Full Text] [Related]
15. Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials.
Maslej MM; Furukawa TA; Cipriani A; Andrews PW; Mulsant BH
JAMA Psychiatry; 2020 Jun; 77(6):607-617. PubMed ID: 32074273
[TBL] [Abstract][Full Text] [Related]
16. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study.
Siwek M; Dudek D; Paul IA; Sowa-Kućma M; Zieba A; Popik P; Pilc A; Nowak G
J Affect Disord; 2009 Nov; 118(1-3):187-95. PubMed ID: 19278731
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
18. Rosa damascena oil improves SSRI-induced sexual dysfunction in male patients suffering from major depressive disorders: results from a double-blind, randomized, and placebo-controlled clinical trial.
Farnia V; Shirzadifar M; Shakeri J; Rezaei M; Bajoghli H; Holsboer-Trachsler E; Brand S
Neuropsychiatr Dis Treat; 2015; 11():625-35. PubMed ID: 25834441
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled phase 2 study of the augmentation of a nicotinic acetylcholine receptor partial agonist in depression: is there a relationship to leptin levels?
Fava M; Ramey T; Pickering E; Kinrys G; Boyer S; Altstiel L
J Clin Psychopharmacol; 2015 Feb; 35(1):51-6. PubMed ID: 25422883
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
